CN101591344B - 一种抗血栓的化合物、其制备方法和用途 - Google Patents
一种抗血栓的化合物、其制备方法和用途 Download PDFInfo
- Publication number
- CN101591344B CN101591344B CN2008100977567A CN200810097756A CN101591344B CN 101591344 B CN101591344 B CN 101591344B CN 2008100977567 A CN2008100977567 A CN 2008100977567A CN 200810097756 A CN200810097756 A CN 200810097756A CN 101591344 B CN101591344 B CN 101591344B
- Authority
- CN
- China
- Prior art keywords
- compound
- formula
- preparation
- pyridine
- halogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 0 *C(C(c1c(*)cccc1)N(CC1)Cc2c1[s]c(OC(*)=O)c2)=O Chemical compound *C(C(c1c(*)cccc1)N(CC1)Cc2c1[s]c(OC(*)=O)c2)=O 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100977567A CN101591344B (zh) | 2008-05-27 | 2008-05-27 | 一种抗血栓的化合物、其制备方法和用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100977567A CN101591344B (zh) | 2008-05-27 | 2008-05-27 | 一种抗血栓的化合物、其制备方法和用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101591344A CN101591344A (zh) | 2009-12-02 |
CN101591344B true CN101591344B (zh) | 2012-12-05 |
Family
ID=41406241
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008100977567A Expired - Fee Related CN101591344B (zh) | 2008-05-27 | 2008-05-27 | 一种抗血栓的化合物、其制备方法和用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101591344B (zh) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101684124B (zh) * | 2008-09-22 | 2013-11-13 | 广州赫尔氏药物开发有限公司 | 新的具有抗凝血作用的化合物 |
CN103936756B (zh) * | 2008-09-22 | 2017-09-19 | 广州赫尔氏药物开发有限公司 | 具有抗凝血作用的化合物 |
WO2011079407A1 (zh) * | 2009-12-28 | 2011-07-07 | 北京益君康医药技术有限公司 | 新的具有抗凝血作用的化合物 |
CN102120744B (zh) * | 2010-02-02 | 2013-01-09 | 江苏威凯尔医药科技有限公司 | 光学活性2-羟基四氢噻吩并吡啶衍生物及其制备方法与在制药中的用途 |
CN102212068A (zh) * | 2010-04-06 | 2011-10-12 | 刘桂坤 | 噻吩衍生物及其制备方法和在药物上的应用 |
MX349974B (es) | 2010-08-26 | 2017-08-22 | Ipca Laboratories Ltd * | Metodo para el tratamiento o profilaxis de trombosis o embolismo. |
CN103517909B (zh) * | 2011-04-14 | 2015-04-08 | 广州赫尔氏药物开发有限公司 | 新型抗血小板化合物的加成盐 |
CN102775421A (zh) * | 2011-05-10 | 2012-11-14 | 江苏威凯尔医药科技有限公司 | 2-羟基四氢噻吩并吡啶衍生物盐酸盐、其制备方法及医药用途 |
CN102827184A (zh) * | 2011-06-13 | 2012-12-19 | 江苏威凯尔医药科技有限公司 | 2-羟基四氢噻吩并吡啶衍生物的多晶型物和药物组合物 |
CN102838617A (zh) * | 2011-06-21 | 2012-12-26 | 江苏威凯尔医药科技有限公司 | (S)-2-(2-烟酰氧基-6,7-二氢噻吩并[3,2-c]吡啶-5(4H)-基)-2-(2-氯苯基)-乙酸甲酯的多晶型物和药物组合物 |
CN103254211B (zh) * | 2012-02-17 | 2015-12-16 | 江苏威凯尔医药科技有限公司 | 一种制备维卡格雷及其衍生物的方法 |
CN105362266A (zh) * | 2014-08-28 | 2016-03-02 | 杭州雷索药业有限公司 | 噻吩并吡啶类化合物或其在药学上可接受的盐在制备治疗或预防癫痫药物中的应用 |
CN107698620A (zh) | 2015-06-23 | 2018-02-16 | 江苏天士力帝益药业有限公司 | 一种氘代噻吩并哌啶衍生物、制备方法及其应用 |
CN107304215A (zh) * | 2016-04-20 | 2017-10-31 | 陕西合成药业股份有限公司 | 噻吩吡啶类衍生物及其制备方法和用途 |
CN114736215B (zh) * | 2022-04-19 | 2023-04-11 | 中荣凯特(北京)生物科技有限公司 | 四氢噻吩并吡啶氘代衍生物及其制备方法和药物用途 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1074446A (zh) * | 1991-09-09 | 1993-07-21 | 三共株式会社 | 羟基吡啶衍生物 |
CN1683373A (zh) * | 2005-02-23 | 2005-10-19 | 天津药物研究院 | 噻吩并吡啶取代的乙酰肼衍生物 |
-
2008
- 2008-05-27 CN CN2008100977567A patent/CN101591344B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1074446A (zh) * | 1991-09-09 | 1993-07-21 | 三共株式会社 | 羟基吡啶衍生物 |
CN1683373A (zh) * | 2005-02-23 | 2005-10-19 | 天津药物研究院 | 噻吩并吡啶取代的乙酰肼衍生物 |
Also Published As
Publication number | Publication date |
---|---|
CN101591344A (zh) | 2009-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101591344B (zh) | 一种抗血栓的化合物、其制备方法和用途 | |
CN105777756B (zh) | 杂芳化合物及其在药物中的应用 | |
CN103221048A (zh) | 取代的4-(硒吩-2(或3)-基氨基)嘧啶化合物及其使用方法 | |
US10316025B2 (en) | Substituted piperazine compounds and methods of use and use thereof | |
JPWO2011071109A1 (ja) | アミノ基を有する縮合ヘテロ環化合物 | |
CN106986863A (zh) | Dna‑pk抑制剂 | |
EP1984377A2 (en) | Inhibitors of tnf alpha , pde4 and b-raf, compositions thereof and methods of use therewith | |
CN106478607B (zh) | 取代的杂芳基化合物及其组合物和用途 | |
CN102149703A (zh) | 抗癌药物及将其用于治疗转移性恶性黑色素瘤及其他癌症 | |
CN107176933A (zh) | 一种含氮烷基化和芳基化亚砜亚胺的吲哚胺-2,3-双加氧酶抑制剂 | |
CA2920410A1 (en) | Thienopiperidine derivative and use thereof | |
CN105829334A (zh) | 尿嘧啶核苷酸类似物及其制备方法和应用 | |
KR20180049056A (ko) | 삼환식 축합피리딘-2-온 유도체 및 이들의 brd4 저해제로서의 용도 | |
CN104926794B (zh) | 取代的杂芳基化合物及其组合物和用途 | |
CN106432246A (zh) | 杂芳化合物及其在药物中的应用 | |
CN103214481B (zh) | 新型咪唑并[1,2-a]吡啶类化合物、其制备方法、包含此类化合物的药物组合物及其用途 | |
CN104974163A (zh) | 取代的杂芳基化合物及其组合物和用途 | |
CN103687852B (zh) | 2-氨基-3-(咪唑-2-基)-吡啶-4-酮衍生物及其作为vegf受体激酶抑制剂的用途 | |
CN101885730B (zh) | 抗血栓的化合物 | |
CN103313599A (zh) | 取代的4-(芳基氨基)硒吩并嘧啶化合物及其使用方法 | |
CN104672250A (zh) | 取代的杂芳基化合物及其组合物和用途 | |
TW200815457A (en) | Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses | |
US20240010658A1 (en) | Abhd6 antagonist | |
CN105367555B (zh) | 取代的杂芳基化合物及其组合物和用途 | |
CN109689642A (zh) | 经单环杂芳基取代的化合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: JIANGSU HANSOH MEDICAL GROUP CO.,LTD. Free format text: FORMER OWNER: LIANYUNGANG HENGBANG PHARMACEUTICAL TECHNOLOGY CO., LTD. Effective date: 20131113 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20131113 Address after: 222047 Lianyungang Development Zone, Jiangsu Patentee after: Jiangsu Hansoh Medical Group Co.,Ltd. Address before: 222047 tenth Industrial Zone, Lianyungang economic and Technological Development Zone, Jiangsu Patentee before: Lianyungang Hengbang Pharmaceutical Technology Co., Ltd. |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160315 Address after: 222047 Lianyungang economic and Technological Development Zone, Jiangsu Patentee after: JIANGSU HANSOH PHARMACEUTICAL GROUP LIANYUNGANG HONGCHUANG PHARMACEUTICAL CO., LTD. Address before: 222047 Lianyungang Development Zone, Jiangsu Patentee before: Jiangsu Hansoh Medical Group Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121205 Termination date: 20170527 |
|
CF01 | Termination of patent right due to non-payment of annual fee |